DBMZX BNY Mellon Sm/Md Cp Gr Z Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Horizon Therapeutics Public Limited (NASDAQ:HZNP), Align Technology (NASDAQ:ALGN), EQT Corp (NYSE:EQT), Sarepta Therapeutics (NASDAQ:SRPT).

The investment seeks long-term growth of capital. To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap and mid-cap U.S. companies. The adviser currently considers small-cap and mid-cap companies to be those companies with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell 2500™ Growth Index (the index), the fund's benchmark index.

The average market capitalization across the BNY Mellon Sm/Md Cp Gr Z MF is 11.8B. The market cap for tickers in the group ranges from 3.18B to 31.02B. CSGP holds the highest valuation in this group at 31.02B. The lowest valued company is WHD at 3.18B.

The average weekly volume growth across all stocks in the BNY Mellon Sm/Md Cp Gr Z MF was -8%. For the same stocks of the MF, the average monthly volume growth was -21% and the average quarterly volume growth was 8%